logo

Daré Bioscience, Inc (DARE)



Trade DARE now with
  Date
  Headline
8/12/2019 8:08:59 AM Daré Bioscience Receives QIDP Designation From FDA For DARE-BV1
6/26/2019 8:23:27 AM Daré Bioscience Completes Recruitment In Pre-Pivotal Trial Of Ovaprene
11/29/2018 8:07:32 AM Daré Bioscience Announces Initiation Of Content Validity Study For Sildenafil Cream, 3.6%
9/17/2018 8:09:26 AM Daré Bioscience Appoints Greg Matz To Board
6/4/2018 8:09:45 AM Daré Bioscience Appoints Mary Jarosz To Newly Created Role Of Global Head Of Regulatory Affairs
5/15/2018 8:07:23 AM Daré Bioscience Announces Trial Initiation For Ovaprene Non-Hormonal Monthly Contraceptive Candidate
5/7/2018 8:10:54 AM Daré Bioscience To Buy Product To Address Vulvar And Vaginal Atrophy In Hormone Receptor-Positive Breast Cancer Patients
4/25/2018 8:09:28 AM Daré Bioscience Enters Worldwide License Deal For Juniper Pharmac’ Intravaginal Ring (IVR)Technology Platform
4/23/2018 6:02:38 AM Innovus Pharma Adds Ryan Selhorn As VP, CFO
4/11/2018 8:05:40 AM Jessica Grossman Joins Daré Bioscience Board
3/12/2018 8:14:46 AM Daré Announces Development And Option Agreement With Orbis Biosciences For Long-acting Injectable Contraceptive